HHS: Taxpayers May Have Overpaid $1.27 Billion For EpiPens

Even though drug company Mylan agreed to pay $465 million to quickly settle a Justice Department investigation into allegations that it deliberately overcharged Medicaid for its EpiPen emergency al…

0
0